Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 6/20 | 0.57 |
| ▸ | SLC1A2 | P43004 | 7/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 10/20 | 0.53 |
| ▸ | GRIK2 | Q13002 | 10/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2160766 | 1.00 | SLC1A1 (0.57) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL5295103 | 0.80 | PTGS1 (0.46) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL11381471 | 0.79 | CHRM1 (0.38) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL4477147 | 0.73 | SLC1A1 (1.00) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL5293587 | 0.73 | SLC1A1 (0.67) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL7103579 | 0.73 | SLC1A1 (1.00) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL27784432 | 0.72 | SLC1A2 (0.64) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL27817249 | 0.72 | SLC1A2 (0.64) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL27806425 | 0.72 | SLC1A2 (0.64) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 | |
| SCHEMBL13621431 | 0.71 | SLC1A1 (0.64) | SLC1A1SLC1A2SLC1A3GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220071917-A9 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2022-03-10 | — | — | US | disclosed |
| US-20210228494-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2021-07-29 | — | — | US | disclosed |
| EP-3703666-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | Universidade de Santiago de Compostela (ES) | 2020-09-09 | — | — | EP | disclosed |
| US-10471020-B2 | Nanoparticles with protected interiors, and methods of use thereof | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2019-11-12 | — | — | US | disclosed |
| US-20180078510-A1 | NANOPARTICLES WITH PROTECTED INTERIORS, AND METHODS OF USE THEREOF | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2018-03-22 | — | — | US | disclosed |
| US-9415019-B2 | Nanocapsules with a polymer shell | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2016-08-16 | — | — | US | disclosed |
| US-20150099808-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | NIRVANA'S TREE HOUSE B.V. (NL) | 2015-04-09 | — | — | US | disclosed |
| US-20140023703-A1 | NANOCAPSULES WITH A POLYMER SHELL | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2014-01-23 | — | — | US | disclosed |
| EP-2664324-A1 | NANOCAPSULES WITH A POLYMER SHELL | Universidade De Santiago De Compostela (ES) | 2013-11-20 | — | — | EP | disclosed |
| US-20110182813-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | NIRVANA'S TREE HOUSE B.V. (NL) | 2011-07-28 | — | — | US | disclosed |
| EP-2042538-A1 | Amphiphilic copolymers and compositions containing such polymers | Nirvana's Tree House (NL) | 2009-04-01 | — | — | EP | disclosed |
| WO-2009037313-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | NIRVANA'S TREE HOUSE B.V. (NL) | 2009-03-26 | — | — | WO | disclosed |
| US-7005123-B1 | Functional poly-α-amino-acid derivatives useful for the modification of biologically active materials and their application | UNIVERSITEIT GENT (BE) | 2006-02-28 | — | — | US | disclosed |
| EP-1189971-B1 | FUNCTIONAL POLY-ALPHA-AMINOACID DERIVATIVES USEFUL FOR THE MODIFICATION OF BIOLOGICALLY ACTIVE MATERIALS AND THEIR APPLICATION | UNIV GENT (BE) | 2005-03-09 | — | — | EP | disclosed |
| US-6590061-B1 | Synthetic polypeptide or peptides having narrow molecular weight distribution used as telechelic polymers for synthesis of block or graft copolymers | INSTITUTE OF MACROMOLECULAR CHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 2003-07-08 | — | — | US | disclosed |
| EP-1088020-B1 | FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | USTAV MAKROMOLEKULARNI CHEMIE (CZ) | 2002-12-18 | — | — | EP | disclosed |
| EP-1189971-A2 | FUNCTIONAL POLY-ALPHA-AMINOACID DERIVATIVES USEFUL FOR THE MODIFICATION OF BIOLOGICALLY ACTIVE MATERIALS AND THEIR APPLICATION | UNIVERSITEIT GENT (BE) | 2002-03-27 | — | — | EP | disclosed |
| EP-1088020-A1 | FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | USTAV MAKROMOLEKULARNI CHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) | 2001-04-04 | — | — | EP | disclosed |
| WO-2000078791-A2 | FUNCTIONAL POLY-α-AMINOACID DERIVATIVES USEFUL FOR THE MODIFICATION OF BIOLOGICALLY ACTIVE MATERIALS AND THEIR APPLICATION | UNIVERSITEIT GENT (BE) | 2000-12-28 | — | — | WO | disclosed |
| WO-1999064495-A1 | FUNCTIONALISED POLYMERS OF α-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VĚD ČESKÉ REPUBLIKY (CZ) | 1999-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228494-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | LNPEP, CLIC1, CLSPN | SLC1A1 254/4885SLC1A2 464/4885SLC1A3 248/4885 |
| US-20110182813-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | GLUL, ASNS, ARGLU1 | SLC1A1 87/4885SLC1A2 84/4885SLC1A3 78/4885 |
| US-20150099808-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | GLUL, ASNS, ARGLU1 | SLC1A1 87/4885SLC1A2 84/4885SLC1A3 78/4885 |
| US-20140023703-A1 | NANOCAPSULES WITH A POLYMER SHELL | PGA5, IL15, CD44 | SLC1A1 4286/4885SLC1A2 4279/4885SLC1A3 4257/4885 |
| US-20220071917-A9 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | LNPEP, CLIC1, CLSPN | SLC1A1 254/4885SLC1A2 464/4885SLC1A3 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.